As we have not not heard anything from the company as to the merger, funding, or anything else, all we have to go on is speculation. Speculation is why we invested in LLSR in the first place. I do not think it is time to throw in the towel, nor revert to name calling. It does none of us any good.

The Dec. 31 deadline for the merger with Perio-Imaging has come and gone. None of us knows for sure what will happen next. None of us knows for sure what the problem is with funding. We can only speculate until Stan makes some kind of announcement. Hopefully soon. Hopefully good.

One concern of mine is the amount of shares outstanding. Appx. 130 million. I think a reduction in the amount of shares to appx. 26 million ( or a 1 for 5 reverse stock split ) would make the company more appealing for funding and/or merger potential. But this is only my oppinion and probably does'nt mean squat.

Regardless of what is to come of the company, we know that OCT works. It is used and accepted in other medical applications and is being researched for the Dental industry ( octnews.org ).

I am hopeful and optimistic that Stan can make something happen and all of us happy. I do not think that crow is on the menu just yet.

LW